Suggestions

Du même auteur

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Archive ouverte | Flinn, Ian | CCSD

International audience. Abstract Duvelisib (also known as IPI-145) is an oral, dual inhibitor of phosphatidylinositol 3-kinase δ and γ (PI3K-δ,γ) being developed for treatment of hematologic malignancies. PI3K-δ,γ s...

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.

Archive ouverte | Morschhauser, Franck | CCSD

International audience. An unmet need exists for patients with relapsed/refractory (R/R) follicular lymphoma (FL) and high-risk disease features, such as progression of disease within 24 months (POD24) from first-li...

Autologous EBV-specific T cell treatment results in sustained responses in patients with advanced extranodal NK/T lymphoma: results of a multicenter study

Archive ouverte | Kim, Won Seog | CCSD

International audience

Chargement des enrichissements...